- CryoPort (NASDAQ:CYRX) plunges as much as 18% after Moderna said its experimental COVID-19 vaccine would not need ultra-cold temperatures to be preserved.
- Moderna says new data showed its vaccine is stable at refrigerator temperatures for 30 days; by comparison, the vaccine being developed by Pfizer and BioNTech needs to be kept in deep freeze until a few days before use.
- https://seekingalpha.com/news/3636659-cryoportminus-13-after-modernas-vaccine-not-need-deep-freeze
Monday, November 16, 2020
CryoPort falls as Moderna's vaccine does not need deep freeze
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.